Form 8-K LILLY ELI & CO For: Oct 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Eli Lilly & Co. (LLY) Tops Q3 EPS by 14c
October 22, 2015 6:26 AM EDTEli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $0.89, $0.14 better than the analyst estimate of $0.75. Revenue for the quarter came in at $4.96 billion versus the consensus estimate of $4.99 billion.
Eli Lilly & Co. sees FY2015 EPS of $3.40-$3.45, versus prior guidance of $3.20-$3.30 and... More
